| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |